361 related articles for article (PubMed ID: 30300581)
1. Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting.
Rotolo A; Caputo VS; Holubova M; Baxan N; Dubois O; Chaudhry MS; Xiao X; Goudevenou K; Pitcher DS; Petevi K; Kachramanoglou C; Iles S; Naresh K; Maher J; Karadimitris A
Cancer Cell; 2018 Oct; 34(4):596-610.e11. PubMed ID: 30300581
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein.
Das R; Guan P; Wiener SJ; Patel NP; Gohl TG; Evans E; Zauderer M; Nichols KE
Blood Adv; 2019 Mar; 3(5):813-824. PubMed ID: 30858151
[TBL] [Abstract][Full Text] [Related]
3. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
4. Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials.
Ramanayake S; Bilmon I; Bishop D; Dubosq MC; Blyth E; Clancy L; Gottlieb D; Micklethwaite K
Cytotherapy; 2015 Sep; 17(9):1251-67. PubMed ID: 26212611
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
[TBL] [Abstract][Full Text] [Related]
6. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
Guan P; Schaub R; Nichols KE; Das R
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
[TBL] [Abstract][Full Text] [Related]
7. Navigating the Role of CD1d/Invariant Natural Killer T-cell/Glycolipid Immune Axis in Multiple Myeloma Evolution: Therapeutic Implications.
Papoutselis M; Spanoudakis E
Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):358-365. PubMed ID: 32234294
[TBL] [Abstract][Full Text] [Related]
8. Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response.
Zeng J; Wang S
Stem Cells Transl Med; 2014 Jan; 3(1):69-80. PubMed ID: 24292792
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment.
Zheng WW; Zhou H; Li P; Ye SG; Abudureheman T; Yang LT; Qing K; Liang AB; Chen KM; Duan CW
Cancer Immunol Immunother; 2023 Nov; 72(11):3739-3753. PubMed ID: 37707586
[TBL] [Abstract][Full Text] [Related]
10. PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity.
Moraes Ribeiro E; Secker KA; Nitulescu AM; Schairer R; Keppeler H; Wesle A; Schmid H; Schmitt A; Neuber B; Chmiest D; Podavini S; Märklin M; Klimovich B; Schmitt M; Korkmaz F; Lengerke C; Schneidawind C; Schneidawind D
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38296597
[TBL] [Abstract][Full Text] [Related]
11. Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo.
Yin Y; Zhang P; He L; Guo X; Wang H; Li J; Xu Q
Evid Based Complement Alternat Med; 2022; 2022():1227308. PubMed ID: 36034960
[TBL] [Abstract][Full Text] [Related]
12. A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer.
Seki T; Liu J; Brutkiewicz RR; Tsuji M
Anticancer Res; 2019 Feb; 39(2):549-555. PubMed ID: 30711929
[TBL] [Abstract][Full Text] [Related]
13. [Construction and evaluation of dual-effect cord blood natural killer cells expressing highaffinity PD-1 and chimeric antigen CD19 receptor].
Zhong H; Zou Q; Liu H; Wang X; DU S; Liang H; Wu Z; Ye J; Zou Q
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1877-1884. PubMed ID: 35012922
[TBL] [Abstract][Full Text] [Related]
14. Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.
Gorini F; Azzimonti L; Delfanti G; Scarfò L; Scielzo C; Bertilaccio MT; Ranghetti P; Gulino A; Doglioni C; Di Napoli A; Capri M; Franceschi C; Caligaris-Cappio F; Ghia P; Bellone M; Dellabona P; Casorati G; de Lalla C
Blood; 2017 Jun; 129(26):3440-3451. PubMed ID: 28465341
[TBL] [Abstract][Full Text] [Related]
15. PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts.
Bishop DC; Xu N; Tse B; O'Brien TA; Gottlieb DJ; Dolnikov A; Micklethwaite KP
Mol Ther; 2018 Aug; 26(8):1883-1895. PubMed ID: 29861327
[TBL] [Abstract][Full Text] [Related]
16. JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells.
Liu J; Gallo RM; Khan MA; Iyer AK; Kratzke IM; Brutkiewicz RR
Eur J Immunol; 2019 Feb; 49(2):255-265. PubMed ID: 30467836
[TBL] [Abstract][Full Text] [Related]
17. Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.
Weinkove R; Brooks CR; Carter JM; Hermans IF; Ronchese F
Haematologica; 2013 Mar; 98(3):376-84. PubMed ID: 23065503
[TBL] [Abstract][Full Text] [Related]
18. A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.
Tsaih SW; Presa M; Khaja S; Ciecko AE; Serreze DV; Chen YG
Genes Immun; 2015; 16(3):221-30. PubMed ID: 25654212
[TBL] [Abstract][Full Text] [Related]
19. CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation.
Zeissig S; Peuker K; Iyer S; Gensollen T; Dougan SK; Olszak T; Kaser A; Blumberg RS
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10449-10454. PubMed ID: 28893990
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid defines cross-species reactivity of tree shrew (Tupaia belangeri) CD1d to human invariant natural killer T (iNKT) cells.
Zhang P; Li D; Stewart-Jones G; Shao X; Zhang Y; Chen Q; Li Y; He YW; Xu XN; Zhang HT
Immunology; 2009 Dec; 128(4):500-10. PubMed ID: 19863613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]